Hear from SIO2020 Program Chair, Sarah White, MD, MS, as she shares...
source:
The Society of Interventional Oncology submitted updates to the NCCN neuroendocrine guidelines. Submitted...
source:
Hear from SIO President-Elect, Matthew Callstrom, MD, PhD, as he shares...
source:
Scientific Chair of the SIO2020 Program Committee, Robert Suh, shares about his career and his focus within...
source:
This study aimed to evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional...
source: Cancer Imaging
Researchers conducted a systematic review for evidence of the clinical efficacy of cancer immunotherapies. they searched PubMed from inception to 14 February, 2018, for meta-analyses of randomized controlled trials...
source: Cancers
Immune checkpoint inhibition suggests promising progress for the treatment of advanced hepatocellular carcinoma (HCC). However, the underlying cellular mechanisms remain unclear because liver cancer cells apparently do not upregulate...
source: Cancer Immunology, Immunotherapy
The American Association for the Study of Liver Diseases recommends ultrasound (US) screening for hepatocellular carcinoma (HCC) among cirrhotic patients, regardless of body mass index (BMI), every...
source: Clinical and Molecular Hepatology
Transcatheter arterial chemoembolization (TACE) is well known as an effective treatment for hepatocellular carcinoma (HCC). In the present study, a novel embolic agent of sodium alginate (SA)-modified...
source: International Journal of Biological Macromolecules
Tumor recurrence is the major risk factor affecting post-transplant survival. In this retrospective study, researchers evaluate the prognostic values of magnetic resonance (MR) diffusion-weighted imaging (DWI)...
source: Cancer Imaging
While resection is a recommended treatment for patients with stage one hepatocellular carcinoma (HCC), it remains controversial for multifocal disease. Researchers sought to identify patients with multifocal HCC with...
source: HPB
Tumor thrombus is an intravascular malign tumor extension that may occur in various types of cancer. Hepatocellular carcinomas (HCC) are common causes of malign thrombus. The presence of a malign thrombus due to HCC has a...
source: Revista Española de Medicina Nuclear e Imagen Molecular
